https://orcid.org/0000-0003-4029-6806
References
- Salvatore S, Ruffolo AF, Phillips C, et al. Vaginal laser therapy for GSM/VVA: where we stand now - A review by the EUGA working group on laser. Climacteric. 2023;26(4):336–352.
- Li FG, Maheux-Lacroix S, Deans R, et al. Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial. JAMA. 2021;326(14):1381–1389.
- Mension E, Alonso I, Anglès-Acedo S, et al. Effect of fractional carbon dioxide vs sham laser on sexual function in survivors of breast cancer receiving aromatase inhibitors for genitourinary syndrome of menopause: the LIGHT randomized clinical trial. JAMA Netw Open. 2023;6(2):e2255697.
- Li F, Fuchs T, Deans R, et al. Vaginal epithelial histology before and after fractional CO2 laser in postmenopausal women: a double-blind, sham-controlled randomized trial. Am J Obstet Gynecol. 2023;229(3):278.e1–278-e9.
- Dutra PFSP, Heinke T, Pinho SC, et al. Comparison of topical fractional CO2 laser and vaginal estrogen for the treatment of genitourinary syndrome in postmenopausal women: a randomized controlled trial. Menopause. 2021;28(7):756–763.
- Wamsley C, Kislevitz M, Vingan NR, et al. A randomized, placebo-controlled trial evaluating the single and combined efficacy of radiofrequency and hybrid fractional laser for nonsurgical aesthetic genital procedures in post-menopausal women. Aesthet Surg J. 2022;42(12):1445–1459.
- Mackova K, Mazzer AM, Mori Da Cunha M, et al. Vaginal Er: YAG laser application in the menopausal ewe model: a randomised estrogen and sham-controlled trial. BJOG. 2021;128(6):1087–1096.